 |
|
VEGFR-2 inhibitor peptide CT-322
A highly specific, vascular endothelial growth factor receptor-2 (VEGFR-2) antagonist with potential antiangiogenic activity. Derived from human fibronectin, VEGFR-2 inhibitor peptide CT-322 may block the activation of VEGFR-2 by all known activating ligands, thereby inhibiting the growth of new tumor blood vessels. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| US brand name: | | Angiocept | | | | Code name: | | CT-322 | | |
| Previous: | vatalanib, VCL-CB01 vaccine, Vectibix, vector-peptide conjugated paclitaxel, Vectrin | | Next: | VEGFR1-1084 peptide vaccine, VEGFR2-169 peptide vaccine, velafermin, Velban, VELCADE |
|
|
